MyAllies NewsBreakingRegulatoryWorldTechnologyBusinessPoliticsEntertainmentHealthSportsTopics
Home › Regulatory

Lyell Immunopharma, Inc. - 10-Q Filing

Lyell Immunopharma reports Q3 2026 financial position including updates on ICT license acquisition and collaborative arrangements.

3 articles from 1 source · updated November 5, 2026, 22:36 UTC

Coverage

  • Lyell Immunopharma, Inc. - 4 Filing SEC EDGAR · November 5, 2026, 22:36 UTC
  • Lyell Immunopharma, Inc. - 4 Filing SEC EDGAR · November 5, 2026, 22:34 UTC
  • Lyell Immunopharma, Inc. - 10-Q Filing SEC EDGAR · November 4, 2026, 21:17 UTC